The chronic use of serotonin norepinephrine reuptake inhibitors facilitates dyskinesia priming in early Parkinson's disease. Marano M, Pilotto A, Padovani A, Gupta D, et al. J Neurol 2024;271:3711-3720.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Marano M, Pilotto A, Padovani A, Gupta D, et al. The chronic use of serotonin norepinephrine reuptake inhibitors facilitates dyskinesia priming in early Parkinson's disease. J Neurol 2024;271:3711-3720.
PMID: 38720139